Product Information
CELLCEPT 200 MG/ML ORAL SUSP is a brand product labeled by Genentech, Inc., priced at $8.3330 per ML under NDC 00004026129. Its NADAC has been published 427 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Mycophenolate Mofetil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/mL
Manufacturer
Genentech, Inc.NDC
00004026129
Classification
Brand
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MYCOPHENOLATE MOFETILApproval Type
New Drug (NDA)
FDA Application
NDA050759On Market Since
10/1/1998
Pharmacological Classes
Price Statistics
The NADAC for CELLCEPT 200 MG/ML ORAL SUSP has been published 427 times since Nov 28, 2013, and over the history we have for it it has risen 39.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.3330 per ML |
|---|---|
| All-time high | $8.4086 (Feb 13, 2019) |
| All-time low | $5.9684 (Nov 28, 2013) |
| 52-week high | $8.3454 |
| 52-week low | $8.3278 |
| Median price | $8.0365 |
| Average price | $7.7269 |
| Largest weekly change | +9.5% (Nov 18, 2015) |
| Weeks tracked | 427 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CELLCEPT 200 MG/ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CELLCEPT 200 MG/ML ORAL SUSP, manufactured by Genentech, Inc., is $8.3330 per ML (NDC 00004026129), effective Jun 24, 2026.
How has the price of CELLCEPT 200 MG/ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for CELLCEPT 200 MG/ML ORAL SUSP has risen 39.6%. It has been tracked across 427 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CELLCEPT 200 MG/ML ORAL SUSP?
Since Nov 28, 2013, the NADAC for CELLCEPT 200 MG/ML ORAL SUSP has ranged from a low of $5.9684 (Nov 28, 2013) to a high of $8.4086 (Feb 13, 2019), with a median of $8.0365 per ML.
Are there cheaper alternatives to CELLCEPT 200 MG/ML ORAL SUSP?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MYCOPHENOLATE 200 MG/ML SUSP, is $0.9324 per ML — about 89% below CELLCEPT 200 MG/ML ORAL SUSP.
Who manufactures CELLCEPT 200 MG/ML ORAL SUSP?
CELLCEPT 200 MG/ML ORAL SUSP (NDC 00004026129) is labeled by Genentech, Inc., and CMS classifies it as a brand product.